Hovione FarmaCiencia SA

Overview

Hovione FarmaCiencia SA is a privately held global pharmaceutical company headquartered in Portugal, specializing in drug substance, drug product intermediates, and particle engineering. Known for providing solutions to complex problems in pharmaceutical development and manufacturing, Hovione serves both major pharmaceutical companies and emerging biotech firms.

Therapeutic areas

API / Drug Master Files

Hovione FarmaCiencia SA holds 14 active (28 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SALMETEROL XINAFOATE INHALATION GRADEActive2017-06-22
• FLUTICASONE FUROATE INHALATION GRADEActive2017-05-31
• MINOCYCLINE HYDROCHLORIDE MICRONIZEDActive2015-01-08
• MOMETASONE FUROATE MONOHYDRATE INHALATION GRADEActive2012-04-23
• FLUTICASONE PROPIONATE INHALATION GRADEActive2011-03-25
• DOXYCYCLINE MONOHYDRATE MICRONIZEDActive2010-03-18
• 05ST03PActive2008-07-08
• HALOBETASOL PROPIONATEActive2003-11-13
• FLUTICASONE PROPIONATEActive2002-12-20
• MOMETASONE 17-FUROATEActive2000-05-26
• MINOCYCLINE HYDROCHLORIDEActive1998-09-01
• DOXYCYCLINE MONOHYDRATEActive1998-09-01
• BETAMETHASONE 21-ACETATEActive1986-11-28
• BETAMETHASONE SODIUM PHOSPHATEActive1986-11-18
• ACLIDINIUM BROMIDE MICRONIZEDInactive2019-12-20

Showing 15 of 28 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Hovione FarmaCiencia SA in our records. PharmaTek screens the full directory against live FDA enforcement data.